NYXH
Nyxoah SA Ordinary Shares
Surgical & Medical Instruments & Apparatus
Best Medical Devices Stocks 2026 →
Nyxoah SA Ordinary Shares (NYXH) Stock: Buy, Sell, or Hold?
$0.90
+0.01 (+0.66%)
▲
5d:
+3.44%
30d:
-31.31%
90d:
-43.04%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
66/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.82 – $1.26
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.1x
Next 12M consensus est.
Wall Street Target
$2.85
+216.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.80 / $0.97
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NYXH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When NYXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NYXH is currently trading at $0.90, which is considered slightly low relative to its 30-day fair value range of $0.82 to $1.26.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $0.80, while resistance sits at $0.97.
Market Sentiment: NYXH scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.85 (+216.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NYXH is in a strong downtrend. Immediate support is located at $0.80, while resistance sits at $0.97.
Market Sentiment: NYXH scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.85 (+216.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.82 -
$1.26
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.82 -
$1.26
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.80
Resistance Level
$0.97
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (91/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 216.9% below Wall St target ($2.85)
- CAUTION: Bottoming setup, but lagging the sector by 12% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-1.11
Wall Street Target
$2.85
(+216.9%)
Revenue Growth (YoY)
365.0%
Share NYXH Analysis
Share this live NYXH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NYXH)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Nyxoah reported Q3 2026 financial results with €9.2 million in global net revenue, driven by 29% sequential growth in U.S. net revenue. The company submitted a PMA supplement to the FDA to expand Genio's U.S. indication and presented the 12-month ACCCESS dataset at the ISSS annual meeting.
Key Retail Themes:
financial performance
regulatory updates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:20 AM ET
Data refreshes hourly during market hours. Next update: 9:20 AM
Data refreshes hourly during market hours. Next update: 9:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NYXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NYXH Research Pages
